AIM ImmunoTech

Business Services · Florida, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

2117 SW Highway 484, Ocala, Florida, 344...

Phone Number

(352) 448-7797

Revenue

<$5 Million

Stock Symbol

AIM

Industry

Business Services Research & Development

About AIM ImmunoTech

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Companys lead product, Ampligen® (rintatolimod), is an immuno-modulator with broad spectrum activity being developed for globally important cancers, viral diseases and disorders of the immune system.Explore more
AIM ImmunoTech's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NYSE: AIMShow more

AIM ImmunoTech Org Chart

Thomas Equels, President & Chief Executive Officer at AIM ImmunoTech
United States flag for contact location.

President & Chief Executive Officer

PhoneEmail
Peter Rodino, Chief Operating Officer, Executive Director, Governmental Relations & General Counsel & Secretary at AIM ImmunoTech
United States flag for contact location.

Chief Operating Officer, Executive Director, ...

PhoneEmail
Robert Dickey, Chief Financial Officer at AIM ImmunoTech
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JM
United States flag for contact location.

Quality Control Associate & Manager

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to AIM ImmunoTech

Compare insights from companies similar to AIM ImmunoTech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

AIM ImmunoTech

<$5M
11-50
Public
-
1966
Thomas Equels, President & Chief Executive Officer at AIM ImmunoTech
Thomas EquelsPresident & CEO
$36.8M
11-50
Public
$304.5M
1998
Paul Sekhri, Chairman, President & Chief Executive Officer at vTv Therapeutics
Paul SekhriChairman, President & CEO
$5.7M
11-50
Private
$245.8M
2015
RM
Robert MansfieldExecutive Director
<$5M
1-10
Public
<$5M
2011
JP
James ParslowChief Financial Officer
<$5M
1-10
Private
-
2019
N/A
<$5M
51-200
Public
$296.1M
1997
Jerome Durso, Chief Executive Officer, President & Chairman at Altimmune
Jerome DursoCEO, President & Chairman
1-10
Public
$12.1M
1965
Alan Urban, Chief Financial Officer at GT Biopharma
Alan UrbanChief Financial Officer
Illustration of an envelope

AIM ImmunoTech Tech Stack

A closer look at the technologies used by AIM ImmunoTech

Top Business Services Companies

Frequently Asked Questions Regarding AIM ImmunoTech

What is AIM ImmunoTech's stock symbol?
AIM ImmunoTech's stock symbol is AIM
What is AIM ImmunoTech's official website?
AIM ImmunoTech's official website is www.aimimmuno.com
What is AIM ImmunoTech's Revenue?
AIM ImmunoTech's revenue is <$5 Million
What is AIM ImmunoTech's SIC code?
AIM ImmunoTech's SIC: 28,283
What is AIM ImmunoTech's NAICS code?
AIM ImmunoTech's NAICS: 32,325
How many employees does AIM ImmunoTech have?
AIM ImmunoTech has 11-50 employees
What industry does AIM ImmunoTech belong to?
AIM ImmunoTech is in the industry of: Business Services, Research & Development
What is AIM ImmunoTech competition?
AIM ImmunoTech top competitors include: GT Biopharma, Altimmune, Bionavigen, Xenetic Biosciences
What technology does AIM ImmunoTech use?
Some of the popular technologies that AIM ImmunoTech uses are: WooCommerce, WordPress.org, PHP, Proofpoint
Who is the CFO of AIM ImmunoTech?
AIM ImmunoTech's CFO is Robert Dickey
How do I contact AIM ImmunoTech?
AIM ImmunoTech contact info: Phone number: (352) 448-7797 Website: www.aimimmuno.com
What does AIM ImmunoTech do?

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Companys lead product, Ampligen® (rintatolimod), is an immuno-modulator with broad spectrum activity being developed for globally important cancers,... viral diseases and disorders of the immune system.Read More

What are AIM ImmunoTech social media links?
AIM ImmunoTech Linkedin page AIM ImmunoTech Twitter page AIM ImmunoTech Facebook page
Is AIM ImmunoTech a public company?
Yes, AIM ImmunoTech is a public company and is traded under the symbol AIM
See more information about AIM ImmunoTech

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.